These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


108 related items for PubMed ID: 8390733

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J, Barrio V, Goicoechea MA, González C, de Vinuesa SG, Gómez F, Bernis C, Espinosa M, Ahijado F, Gómez J, Escalada P.
    Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
    [Abstract] [Full Text] [Related]

  • 5. Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism.
    Hernández D, Lacalzada J, Salido E, Linares J, Barragán A, Lorenzo V, Higueras L, Martín B, Rodríguez A, Laynez I, González-Posada JM, Torres A.
    Kidney Int; 2000 Aug; 58(2):889-97. PubMed ID: 10916115
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
    August P, Cody RJ, Sealey JE, Laragh JH.
    Am J Hypertens; 1989 Aug; 2(8):599-603. PubMed ID: 2550029
    [Abstract] [Full Text] [Related]

  • 7. Low dose angiotensin converting enzyme inhibition and glomerular permselectivity in renal transplant recipients.
    Borchhardt K, Haas N, Yilmaz N, Oberbauer R, Schmidt A, Barnas U, Mayer G.
    Kidney Int; 1997 Dec; 52(6):1622-5. PubMed ID: 9407509
    [Abstract] [Full Text] [Related]

  • 8. Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril.
    Midtvedt K, Hartmann A, Foss A, Fauchald P, Nordal KP, Rootwelt K, Holdaas H.
    Transplantation; 2001 Dec 15; 72(11):1787-92. PubMed ID: 11740389
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure.
    Wühl E, Mehls O, Schaefer F, ESCAPE Trial Group.
    Kidney Int; 2004 Aug 15; 66(2):768-76. PubMed ID: 15253732
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B, Kobelt V, Erfmann M, Hausberg M, Gerhardt U, Rahn KH, Hohage H.
    Transpl Int; 2003 May 15; 16(5):313-20. PubMed ID: 12759722
    [Abstract] [Full Text] [Related]

  • 11. Acute and chronic effects of lisinopril on renal and systemic hemodynamics in hypertension.
    Degaute JP, Leeman M, Reuse C, Carlier E, Schoutens A, Vandepapeliere P.
    Cardiovasc Drugs Ther; 1992 Oct 15; 6(5):489-94. PubMed ID: 1333275
    [Abstract] [Full Text] [Related]

  • 12. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R.
    Kidney Int; 2001 Jun 15; 59(6):2282-9. PubMed ID: 11380832
    [Abstract] [Full Text] [Related]

  • 13. Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function.
    Palla R, Panichi V, Finato V, Parrini M, Andreini B, Bianchi AM, Giovannini L, Migliori M, Bertelli AA.
    Int J Clin Pharmacol Res; 1994 Jun 15; 14(1):35-43. PubMed ID: 7927959
    [Abstract] [Full Text] [Related]

  • 14. Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats.
    Remuzzi A, Imberti O, Puntorieri S, Malanchini B, Macconi D, Magrini L, Bertani T, Remuzzi G.
    Am J Physiol; 1994 Dec 15; 267(6 Pt 2):F1034-44. PubMed ID: 7528985
    [Abstract] [Full Text] [Related]

  • 15. Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants.
    Mourad G, Ribstein J, Mimran A.
    Kidney Int; 1993 Feb 15; 43(2):419-25. PubMed ID: 8382753
    [Abstract] [Full Text] [Related]

  • 16. Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: a double-blind, randomized prospective study.
    Janssen JJ, Gans RO, van der Meulen J, Pijpers R, ter Wee PM.
    Am J Hypertens; 1998 Sep 15; 11(9):1074-9. PubMed ID: 9752892
    [Abstract] [Full Text] [Related]

  • 17. Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria.
    Brown SA, Walton CL, Crawford P, Bakris GL.
    Kidney Int; 1993 Jun 15; 43(6):1210-8. PubMed ID: 8391095
    [Abstract] [Full Text] [Related]

  • 18. Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure.
    August P, Lenz T, Laragh JH.
    Am J Hypertens; 1993 Apr 15; 6(4):148S-154S. PubMed ID: 8389563
    [Abstract] [Full Text] [Related]

  • 19. Renal tubular peptide catabolism in chronic vascular rejection.
    Rustom R, Grime JS, Sells RA, Amara A, Jackson MJ, Shenkin A, Maltby P, Smith L, Hammad A, Brown M, Bone JM.
    Ren Fail; 2001 Apr 15; 23(3-4):517-31. PubMed ID: 11499566
    [Abstract] [Full Text] [Related]

  • 20. Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies.
    Cinotti GA, Zucchelli PC, Collaborative Study Group.
    Nephrol Dial Transplant; 2001 May 15; 16(5):961-6. PubMed ID: 11328901
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.